Pharmacogenetic and germline prognostic markers of lung cancer.
Anne M Horgan, Boming Yang, Abul Kalam Azad, Eitan Amir, Thomas John, David W Cescon, Paul Wheatley-Price, Rayjean J Hung, Frances A Shepherd, Geoffrey Liu
Journal of Thoracic Oncology | Published : 2011
INTRODUCTION: Lung cancer is the leading global cause of cancer-related mortality. Interindividual variability in treatment response and cancer outcomes has focused attention on genetic polymorphisms as prognostic markers. We evaluated the overall contribution of candidate polymorphism association studies to our current understanding of the genetic predictors of lung cancer outcomes. METHODS: We examined the results of 90 studies that evaluated associations between genetic polymorphisms and lung cancer outcomes published between January 1990 and May 2009. RESULTS: A total of 170 genetic variations in 90 studies were identified. Overall survival was a primary outcome in 81% of the studies and..View full abstract